iTeos Therapeutics Inc.
7.68
0.02 (0.26%)
At close: Jan 15, 2025, 11:48 AM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -3.48 7.18 7.64 -31.16 -29.71 -7.92
PS Ratio 31.09 2.59 4.75 n/a n/a n/a
PB Ratio 0.68 1.05 2.96 3.67 42.58 9.51
P/FCF Ratio -3.67 -6.19 3.20 -46.42 -27.96 -7.4
P/OCF Ratio -3.77 -6.24 3.19 -47.08 -28.83 -7.49
OCF/S Ratio -8.24 -0.42 1.49 n/a n/a n/a
Debt / Equity Ratio 0.01 0.01 0.01 n/a 0.34 0.42
Quick Ratio 13.76 14.96 2.91 22.66 1.98 4.72
Current Ratio 13.76 14.96 2.88 22.64 1.98 4.72
Asset Turnover 0.02 0.35 0.39 n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a -325.77
Return on Equity (ROE) -0.2 0.15 0.39 -0.12 -1.43 -1.2
Return on Assets (ROA) -0.17 0.13 0.24 -0.11 -0.73 -0.66
Return on Capital (ROIC) -0.24 0.18 0.42 -0.14 -1.6 -0.96
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin 92.87% 99.70% 99.82% n/a n/a n/a
Net Profit Margin -894.34% 36.11% 62.22% n/a n/a n/a
Pretax Profit Margin -865.66% 55.58% 74.39% n/a n/a n/a
Operating Profit Margin -1.20K% 47.20% 71.03% n/a n/a n/a
FCF Margin -847.34% -41.9% 148.49% n/a n/a n/a
EBITDA Margin -1.20K% 55.44% 74.56% n/a n/a n/a